Get Premium to unlock powerful stock data

Omega Fund Management, LLC Buys Theseus Pharmaceuticals Inc, Sells Atea Pharmaceuticals Inc, Cidara Therapeutics Inc, Paratek Pharmaceuticals Inc

Author's Avatar
Feb 15, 2022
Article's Main Image
Investment company Omega Fund Management, LLC (Current Portfolio) buys Theseus Pharmaceuticals Inc, sells Atea Pharmaceuticals Inc, Cidara Therapeutics Inc, Paratek Pharmaceuticals Inc, ObsEva SA, Trevi Therapeutics Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Omega Fund Management, LLC. As of 2021Q4, Omega Fund Management, LLC owns 22 stocks with a total value of $707 million. These are the details of the buys and sells.

For the details of Omega Fund Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/omega+fund+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Omega Fund Management, LLC
  1. Nuvation Bio Inc (NUVB) - 22,957,340 shares, 27.59% of the total portfolio. Shares reduced by 18.63%
  2. Replimune Group Inc (REPL) - 4,763,380 shares, 18.25% of the total portfolio. Shares reduced by 2.71%
  3. Imago BioSciences Inc (IMGO) - 3,018,737 shares, 10.12% of the total portfolio.
  4. Morphic Holding Inc (MORF) - 1,200,014 shares, 8.04% of the total portfolio. Shares reduced by 8.81%
  5. Kronos Bio Inc (KRON) - 3,818,283 shares, 7.34% of the total portfolio.
New Purchase: Theseus Pharmaceuticals Inc (THRX)

Omega Fund Management, LLC initiated holding in Theseus Pharmaceuticals Inc. The purchase prices were between $8.98 and $20.09, with an estimated average price of $15.08. The stock is now traded at around $11.810000. The impact to a portfolio due to this purchase was 1.28%. The holding were 711,479 shares as of 2021-12-31.

Sold Out: Atea Pharmaceuticals Inc (AVIR)

Omega Fund Management, LLC sold out a holding in Atea Pharmaceuticals Inc. The sale prices were between $7.67 and $44.59, with an estimated average price of $14.96.

Sold Out: Cidara Therapeutics Inc (CDTX)

Omega Fund Management, LLC sold out a holding in Cidara Therapeutics Inc. The sale prices were between $1.18 and $1.96, with an estimated average price of $1.54.

Sold Out: ObsEva SA (OBSV)

Omega Fund Management, LLC sold out a holding in ObsEva SA. The sale prices were between $1.99 and $3.01, with an estimated average price of $2.4.

Sold Out: Trevi Therapeutics Inc (TRVI)

Omega Fund Management, LLC sold out a holding in Trevi Therapeutics Inc. The sale prices were between $0.68 and $1.5, with an estimated average price of $1.04.

Sold Out: FibroGen Inc (FGEN)

Omega Fund Management, LLC sold out a holding in FibroGen Inc. The sale prices were between $9.93 and $15.39, with an estimated average price of $12.54.



Here is the complete portfolio of Omega Fund Management, LLC. Also check out:

1. Omega Fund Management, LLC's Undervalued Stocks
2. Omega Fund Management, LLC's Top Growth Companies, and
3. Omega Fund Management, LLC's High Yield stocks
4. Stocks that Omega Fund Management, LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles